BioNote, Inc. (KRX:377740)
South Korea · Delayed Price · Currency is KRW 4,720.00
-50.00 (-1.05%)
Last updated: Jun 4, 2026, 11:00 AM KST
BioNote Market Cap
BioNote has a market cap or net worth of 482.68 billion as of June 3, 2026. Its market cap has increased by 4.20% in one year.
Market Cap
482.68B
Enterprise Value
122.67B
Revenue
122.44B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,720.00
Market Cap Chart
Since December 22, 2022, BioNote's market cap has decreased from 1.08T to 482.68B, a decrease of -55.51%. That is a compound annual growth rate of -20.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 482.68B | -12.94% |
| Dec 30, 2025 | 554.45B | 15.35% |
| Dec 30, 2024 | 480.68B | 10.95% |
| Dec 28, 2023 | 433.23B | -50.44% |
| Dec 29, 2022 | 874.10B | -19.44% |
| Dec 22, 2022 | 1.08T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CLASSYS | 2.78T |
| SD Biosensor | 884.90B |
| T&L Co., Ltd. | 436.13B |
| Value Added Technology | 278.07B |
| Vieworks | 227.02B |
| Dongbang Medical | 135.23B |
| Shinhung | 126.13B |
| EOFLOW | 51.11B |